Literature DB >> 25559593

High prevalence of transmitted drug resistance in acute HIV-infected Thai men who have sex with men.

Jintanat Ananworanich1, Sunee Sirivichayakul, Suteeraporn Pinyakorn, Trevor A Crowell, Rapee Trichavaroj, Jessica Weerayingyong, Nitiya Chomchey, James L K Fletcher, Frits van Griensven, Praphan Phanuphak, Merlin L Robb, Nelson L Michael, Jerome H Kim, Nittaya Phanuphak.   

Abstract

: As use of antiretroviral therapy in Thailand increases, so does the potential for transmission of drug-resistant HIV. We describe the prevalence of WHO surveillance drug resistance mutations among 120 subjects who underwent genotypic testing during acute HIV infection in Bangkok, Thailand. In this cohort of predominantly men who have sex with men, we observed an overall transmitted drug resistance prevalence of 9.2%, including nucleoside/nucleotide analog reverse transcriptase inhibitor 5.0%, nonnucleoside analog reverse transcriptase inhibitor 3.4%, and protease inhibitor 3.4%. These prevalence estimates are higher than previous reports of transmitted drug resistance in Thailand. Baseline drug resistance testing may be warranted, particularly among men who have sex with men.

Entities:  

Mesh:

Year:  2015        PMID: 25559593     DOI: 10.1097/QAI.0000000000000502

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  6 in total

1.  Declining trend in transmitted drug resistance detected in a prospective cohort study of acute HIV infection in Bangkok, Thailand.

Authors:  Donn J Colby; Trevor A Crowell; Sunee Sirivichayakul; Suteeraporn Pinyakorn; Eugene Kroon; Khunthalee Benjapornpong; Jintana Intasan; Rapee Trichavaroj; Sodsai Tovanabutra; Merlin Robb; Praphan Phanuphak; Jintanat Ananworanich; Nittaya Phanuphak
Journal:  J Int AIDS Soc       Date:  2016-10-31       Impact factor: 5.396

Review 2.  Transmitted Drug Resistance in Antiretroviral Therapy-Naive Persons With Acute/Early/Primary HIV Infection: A Systematic Review and Meta-Analysis.

Authors:  Chunxiang Guo; Yaxin Wu; Yang Zhang; Xinchao Liu; Aixin Li; Meixia Gao; Tong Zhang; Hao Wu; Guanzhi Chen; Xiaojie Huang
Journal:  Front Pharmacol       Date:  2021-11-24       Impact factor: 5.810

3.  High efficacy of switching to bictegravir/emtricitabine/tenofovir alafenamide in people with suppressed HIV and preexisting M184V/I.

Authors:  Paul E Sax; Kristen Andreatta; Jean-Michel Molina; Eric S Daar; Debbie Hagins; Rima Acosta; Michelle L D'Antoni; Silvia Chang; Ross Martin; Hui Liu; Christiana Blair; Ian McNicholl; Joel Gallant; Sean E Collins; Hal Martin; Kirsten L White
Journal:  AIDS       Date:  2022-04-23       Impact factor: 4.632

4.  Brief Report: Prevalence Trend of Transmitted Drug Resistance in a Prospective Cohort of Thai People With Acute HIV Infection.

Authors:  Camilla Muccini; Suteeraporn Pinyakorn; Sunee Sirivichayakul; Eugene Kroon; Carlo Sacdalan; Trevor A Crowell; Rapee Trichavaroj; Jintanat Ananworanich; Sandhya Vasan; Nittaya Phanuphak; Donn J Colby
Journal:  J Acquir Immune Defic Syndr       Date:  2021-08-15       Impact factor: 3.771

5.  Performance of the Bio-Rad Geenius HIV1/2 Supplemental Assay in Detecting "Recent" HIV Infection and Calculating Population Incidence.

Authors:  Sheila M Keating; Reshma Kassanjee; Mila Lebedeva; Shelley N Facente; Jeffrey C MacArthur; Eduard Grebe; Gary Murphy; Alex Welte; Jeffrey N Martin; Susan Little; Matthew A Price; Esper G Kallas; Michael P Busch; Christopher D Pilcher
Journal:  J Acquir Immune Defic Syndr       Date:  2016-12-15       Impact factor: 3.731

6.  Transmitted drug resistance in patients with acute/recent HIV infection in Brazil.

Authors:  Ana Cristina G Ferreira; Lara E Coelho; Eduarda Grinsztejn; Carlos S de Jesus; Monick L Guimarães; Valdiléa G Veloso; Beatriz Grinsztejn; Sandra W Cardoso
Journal:  Braz J Infect Dis       Date:  2017-05-21       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.